Akbari M, Nayeri H, Nasri H. Relationship of fetuin-A with nonalcoholic fatty liver. J Prev Epidemiol 2018; 3(2) e04
Raszeja-Wyszomirska J, Szymanik B, Lawniczak M, et al. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol 2010; 10.
Ampuero J, Aller R, Gallego-Durán R, et al. Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practiceJournal of Hepatology 2018; 68: S65-104.
Ratziu V, Massard J, Charlotte F, et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006; 6: 6.
Adams LA, George J, Bugianesi E, et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011; 26(10): 1536-43.
Petta S, Maida M, Macaluso FS, et al. The severity of steatosis influences liver stiffness measurement in patients with non-alcoholic fatty liver disease. Hepatology 2015. Epub ahead of print
Gani RA, Hasan I, Sanityoso A, et al. Evaluation of acoustic radioation force impulse (ARFI) for fibrosis staging in chronic liver diseases. Acta Med Indones - Indones. J Intern Med 2017; 19(2): 128-35.
Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol 2016; 65(5): 1006-16.
Asrani SK. Incorporation of noninvasive measures of liver fibrosis into clinical practice: diagnosis and prognosis. Clin Gastroenterol Hepatol 2015; 2190-04.
Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C Gastroenterology 2012; 142: 1293-302.